Home > Financial Ratios > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
BAFNA PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Last 5 Year EBIT Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Growth(%) -29.41127.17-8.50468.5088.93

What is the latest EBIT Growth ratio of BAFNA PHARMACEUTICALS ?

The latest EBIT Growth ratio of BAFNA PHARMACEUTICALS is -29.41 based on Mar2024 Standalone results.
Year EBIT Growth
Mar2024-29.41
Mar2023127.17
Mar2022-8.50
Mar2021468.50
Mar202088.93

How is EBIT Growth of BAFNA PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2024 -29.41
Negative
Mar2023 127.17
Positive
Mar2022 -8.5
Negative
Mar2021 468.5
426.82
Mar2020 88.93 -

Other Financial Ratios of BAFNA PHARMACEUTICALS


Compare EBIT Growth ratio of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹183.5 Cr -8.2% -3.2% -4.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹409,303.0 Cr 1.4% -4.1% 32.1% Stock Analytics
DIVIS LABORATORIES ₹143,389.0 Cr -4.2% -5.1% 59.6% Stock Analytics
CIPLA ₹114,645.0 Cr -2.2% -7.3% 0.2% Stock Analytics
DR REDDYS LABORATORIES ₹98,449.5 Cr -7.1% -13.8% 8% Stock Analytics
ZYDUS LIFESCIENCES ₹91,587.4 Cr -6.4% -5.2% 31.2% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

-8.2%

-3.2%

-4.8%

SENSEX

0.1%

-3.6%

7.9%


You may also like the below Video Courses